Premium
Translating In Vitro Acrolein‐Trapping Capacities of Tea Polyphenol and Soy Genistein to In Vivo Situation is Mediated by the Bioavailability and Biotransformation of Individual Polyphenols
Author(s) -
Huang Qiju,
Zhu Yingdong,
Lv Lishuang,
Sang Shengmin
Publication year - 2020
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201900274
Subject(s) - genistein , bioavailability , polyphenol , in vivo , chemistry , acrolein , biotransformation , in vitro , pharmacology , biochemistry , epigallocatechin gallate , antioxidant , food science , biology , enzyme , endocrinology , microbiology and biotechnology , catalysis
Scope Acrolein (ACR) is a highly toxic unsaturated aldehyde. Humans are both endogenously and exogenously exposed to ACR. Long‐term exposure to ACR leads to various chronic diseases. Dietary polyphenols have been reported to be able to attenuate ACR‐induced toxicity in vitro via formation of ACR‐polyphenol conjugates. However, whether in vitro ACR‐trapping abilities of polyphenols can be maintained under in vivo environments is still unknown. Methods and results Two most commonly consumed dietary polyphenols, (−)‐epigallocatechin‐3‐gallate (EGCG) from tea and genistein from soy, are evaluated for their anti‐Acrolein behaviors both in vitro and in mice. Tea EGCG exerts a much higher capacity to capture ACR than soy genistein in vitro. But translation of in vitro anti‐ACR activity into in vivo is mainly mediated by bioavailability and biotransformation of individual polyphenols. It is found that 1) both absorbed EGCG and genistein can trap endogenous ACR by forming mono‐ACR adducts and eventually be excreted into mouse urine; 2) both absorbed EGCG and genistein can produce active metabolites, methyl‐EGCG (MeEGCG) and orobol, to scavenge endogenous ACR; 3) both MeEGCG and non‐absorbed EGCG show ability to trap ACR in the gut; 4) considerable amounts of microbial metabolites of genistein display enhanced anti‐ACR capacity both in the body and in the gut, compared to genistein; and 5) biotransformation of genistein is able to boost its in vivo anti‐ACR capacity, compared to EGCG. Conclusion The findings demonstrate that in vivo anti‐ACR ability of dietary polyphenols cannot be reflected solely based on their in vitro ability. The bioavailability and biotransformation of individual polyphenols, and especially the gut microbiome, contribute to in vivo anti‐ACR ability of dietary polyphenols.